The mode of action of prostaglandin (PG) I1 analog, SM-10906, on fibroblasts of hypertrophic scars is similar to PGE1 in its potential role of preventing scar formation

Experimental Dermatology

Volumn 6, Issue 6, 1997, Pages 314-320

  Zhou, L J ^a   Inoue, M ^a   Ono, I ^a   Kaneko, Fumio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagenase; Cytokines; Prostaglandin E1; Prostaglandin I1 analog; Scar fibroblasts

Indexed keywords

11,15 DIHYDROXY 17 METHYL 20 HOMO 6,9 METHANO 3 OXAPROST 13 ENOIC ACID; COLLAGEN TYPE 1; COLLAGENASE; CYCLIC AMP; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; MALE; SCAR; SCAR FORMATION;

EID: 0030710959     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1997.tb00179.x     Document Type: Article

References (18)

1. Ivanics J, Simonidesz V, Galambos G, Kovacs G. Synthesis of prostacyclin analogues via knoevenagel condensation. Tetrahedron Lett 1983: 24: 315-318.
2. 1. Arzneimittelforschung 1994: 44: 483-490.
3. Moncada S, Gryglewski R J, Bunting S, Vane J R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976: 263: 663-665.
4. Goldyne M E. Prostaglandins and cutaneous inflammation. J Invest Dermatol 1975: 64: 377-385.
5. Morisaki S. Effect of topical application of prostaglandin E] ointment on chronic skin ulcers and relation between tissue oxygen tension and its clinical efficacy (in Japanese). Skin Res 1993: 35: 210-218.
6. 1 on human keratinocytes and dermal fibroblasts: A possible mechanism for the healing of skin ulcers. Exp Dermatol 1994: 3: 164-170.
7. 1 for the treatment of burned ulcers. Burns 1996: 22: 399-405.
8. 1 on cultured dermal fibroblasts from normal and hypertrophic scarred skin. J Dermatol Sci 1997: 14: 217-224.
9. 1 derivatives and their biological properties. Chem Lett 1993: 3: 2821-2826.
10. 1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells. Biol Pharm Bull 1994: 17: 74-77.
11. 1: therapeutic potential for wound healing. Arch Dermatol Res 1995: 287: 539-545.
12. Ohshima M, Kuwata F, Sasai Y, Otsuka K, Suzuki K. Collagenase and collagenase inhibitors secreted by cultured human periodontal ligament cells. J Nihon Univ Sch Dent 1993: 35: 109-117.
13. 1. Tetrahedron Lett 1980; 21: 169-172.
14. 1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Burger's disease. Anesthesiol (Japanese) 1992: 41: 1000-1003.
15. Negishi M, Sugimoto Y, Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochem et Biophys Acta 1995: 1259: 109-120.
16. Katsuyama M, Sugimoto Y, Namba T et al. Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett 1994: 344: 74-78.
17. 2 subtype. J Biol Chem 1994: 269: 11873-11877.
18. 2 subtype. Prostaglandins 1994: 47: 151-168.